Blog

Regeneus forms stem cell manufacturing partnership with Cryosite – Proactive Investors Australia


Proactive Investors Australia

Regeneus forms stem cell manufacturing partnership with Cryosite
Proactive Investors Australia
Cryosite will provide production facilities for Regeneus' off-the-shelf allogeneic stem cell product for human osteoarthritis (Progenza). The product, to be used for clinical trial purposes, will be manufactured within Cryosite's good manufacturing

2014-08-21 NEWS
About Michael Zand

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.